DE60206599D1 - Biotin-derivate und ihre konjugaten mit chelatierungsmitteln - Google Patents

Biotin-derivate und ihre konjugaten mit chelatierungsmitteln

Info

Publication number
DE60206599D1
DE60206599D1 DE60206599T DE60206599T DE60206599D1 DE 60206599 D1 DE60206599 D1 DE 60206599D1 DE 60206599 T DE60206599 T DE 60206599T DE 60206599 T DE60206599 T DE 60206599T DE 60206599 D1 DE60206599 D1 DE 60206599D1
Authority
DE
Germany
Prior art keywords
conjugates
chelating agents
biotin derivatives
preparation
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60206599T
Other languages
English (en)
Other versions
DE60206599T2 (de
Inventor
Giovanni Paganelli
Marco Chinol
Mauro Ginanneschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of DE60206599D1 publication Critical patent/DE60206599D1/de
Application granted granted Critical
Publication of DE60206599T2 publication Critical patent/DE60206599T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
DE60206599T 2001-02-16 2002-02-15 Biotin-derivate und ihre konjugaten mit chelatierungsmitteln Expired - Lifetime DE60206599T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM20010079 2001-02-16
IT2001RM000079A ITRM20010079A1 (it) 2001-02-16 2001-02-16 Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
PCT/IT2002/000091 WO2002066075A2 (en) 2001-02-16 2002-02-15 Biotin-derivatives and their conjugates with chelating agents

Publications (2)

Publication Number Publication Date
DE60206599D1 true DE60206599D1 (de) 2005-11-17
DE60206599T2 DE60206599T2 (de) 2006-06-22

Family

ID=11455227

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60206599T Expired - Lifetime DE60206599T2 (de) 2001-02-16 2002-02-15 Biotin-derivate und ihre konjugaten mit chelatierungsmitteln

Country Status (19)

Country Link
US (2) US7390828B2 (de)
EP (1) EP1359943B1 (de)
JP (1) JP4469133B2 (de)
KR (1) KR100860062B1 (de)
CN (1) CN100457192C (de)
AT (1) ATE306283T1 (de)
AU (1) AU2002237517B2 (de)
BR (1) BR0207327A (de)
CZ (1) CZ305442B6 (de)
DE (1) DE60206599T2 (de)
DK (1) DK1359943T3 (de)
ES (1) ES2248522T3 (de)
HK (1) HK1068251A1 (de)
HU (1) HU229160B1 (de)
IT (1) ITRM20010079A1 (de)
MX (1) MXPA03007317A (de)
PL (1) PL202898B1 (de)
SK (1) SK286112B6 (de)
WO (1) WO2002066075A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030196A1 (it) * 2003-04-24 2004-10-25 Sigma Tau Ind Farmaceuti Uso di reagenti per la preparazione di un medicamento
ITRM20040105A1 (it) 2004-02-27 2004-05-27 Tecnogen Scpa Anticorpo monoclonale antitenascina umana.
ITRM20050345A1 (it) 2005-06-30 2007-01-01 Sigma Tau Ind Farmaceuti Sintesi di deossi-biotinil esametilen diammina-dota.
TWI381852B (zh) * 2005-09-27 2013-01-11 Sigma Tau Ind Farmaceuti 生物素二胺基衍生物類及其與大環螯合劑之共軛物
EA023679B1 (ru) 2007-04-04 2016-06-30 Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. АНТИ-EpCAM АНТИТЕЛО И ЕГО ПРИМЕНЕНИЕ
GB0922369D0 (en) * 2009-12-22 2010-02-03 Hammersmith Imanet Ltd Labelled biotin conjugates
CN103370311A (zh) * 2010-10-22 2013-10-23 斯特拉斯堡大学 用于治疗HSP90相关病状的Pochoxime缀合物
BR112014002593B1 (pt) 2011-08-02 2022-11-29 Alfasigma S.p.A Composição farmacêutica de avidina oxidada apropriada para inalação e kits relacionados

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075010A (en) * 1992-06-09 2000-06-13 Neorx Corporation Small molecular weight ligand-hexose containing clearing agents
US5283342A (en) * 1992-06-09 1994-02-01 Neorx Corporation Biotinylated small molecules
US6416738B1 (en) * 1973-12-07 2002-07-09 Neorx Corporation Pretargeting methods and compounds
DE3713842A1 (de) * 1987-04-22 1988-11-17 Schering Ag Substituierte cyclische komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
IT1245748B (it) 1990-12-21 1994-10-14 Mini Ricerca Scient Tecnolog Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
US5624896A (en) * 1992-06-09 1997-04-29 Neorx Corporation Clearing agents useful in pretargeting methods
US6358490B2 (en) * 1992-06-09 2002-03-19 Neorx Corporation Three-step pretargeting methods and compounds
JPH07507804A (ja) * 1992-06-09 1995-08-31 ネオルックス　コーポレーション 予備標的化方法及び化合物
US5911969A (en) * 1992-06-09 1999-06-15 Neorx Corporation Pretargeting protocols for enhanced localization of active agents to target sites
US5578287A (en) * 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
US5976535A (en) * 1992-06-09 1999-11-02 Neorx Corporation Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
US5914312A (en) * 1992-06-09 1999-06-22 Neorx Corporation Pretargeting methods and compounds
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
US5616690A (en) * 1992-06-09 1997-04-01 Neorx Corporation Hexose derivatized human serum albumin clearing agents
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US6120768A (en) * 1993-05-17 2000-09-19 Immunomedics, Inc. Dota-biotin derivatives
JPH0730748U (ja) * 1993-11-29 1995-06-13 花王株式会社 歯ブラシ
US5955605A (en) * 1995-02-21 1999-09-21 Neorx Corporation Biotinidase resistant biotin-DOTA conjugates
CA2232411A1 (en) * 1995-09-18 1997-03-27 Mallinckrodt Medical, Inc. (radio) labelled biotin derivatives
JP3427871B2 (ja) * 1996-06-24 2003-07-22 戸田工業株式会社 コバルト被着型針状磁性酸化鉄粒子粉末
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms

Also Published As

Publication number Publication date
SK286112B6 (sk) 2008-03-05
EP1359943A2 (de) 2003-11-12
EP1359943B1 (de) 2005-10-12
ES2248522T3 (es) 2006-03-16
PL202898B1 (pl) 2009-08-31
ITRM20010079A1 (it) 2002-08-16
CN1531445A (zh) 2004-09-22
AU2002237517B2 (en) 2006-11-30
WO2002066075A3 (en) 2003-01-30
US7390828B2 (en) 2008-06-24
CZ305442B6 (cs) 2015-09-23
JP4469133B2 (ja) 2010-05-26
HUP0303151A2 (hu) 2003-12-29
BR0207327A (pt) 2004-02-10
US20080085239A1 (en) 2008-04-10
US8044081B2 (en) 2011-10-25
KR100860062B1 (ko) 2008-09-24
JP2004524305A (ja) 2004-08-12
HU229160B1 (hu) 2013-09-30
US20040067199A1 (en) 2004-04-08
CZ20031989A3 (cs) 2004-02-18
ITRM20010079A0 (it) 2001-02-16
MXPA03007317A (es) 2004-06-30
SK11152003A3 (sk) 2004-02-03
DE60206599T2 (de) 2006-06-22
ATE306283T1 (de) 2005-10-15
WO2002066075A2 (en) 2002-08-29
HUP0303151A3 (en) 2010-01-28
KR20030072627A (ko) 2003-09-15
DK1359943T3 (da) 2006-01-02
PL365279A1 (en) 2004-12-27
CN100457192C (zh) 2009-02-04
HK1068251A1 (en) 2005-04-29

Similar Documents

Publication Publication Date Title
ATE302775T1 (de) Carbolinderivate
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
YU21401A (sh) Tetrahidropiridoetri
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
UA85559C2 (en) Aminobenzophenone compounds
ATE346067T1 (de) Carbolinderivate
PT1244650E (pt) Derivados arilaminas e sua aplicacao como agentes anti-telomerase
CY1108808T1 (el) Ενωσεις μοτιλιδης
HK1068251A1 (en) Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents
ATE355288T1 (de) Verbindungen und therapeutische methoden
PT1381611E (pt) Analogos de ftalocianina substituidas com metal sem centro de simetria sua preparacao e uso em terapia fotodinamica e em diagnostico in vivo
ATE386742T1 (de) Imidazonaphthyridine
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
EA200200876A1 (ru) Алкилированные производные имидазопиридина
IS5161A (is) Tetrahýdrópýridóefnasambönd
SE9903290D0 (sv) Novel compounds
TW200744647A (en) Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
EA200200883A1 (ru) Производные пирано[2,3-с]имидазо[1,2-а]пиридина для лечения заболеваний желудочно-кишечного тракта
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
BRPI0415038A (pt) derivados de imidazo (4,5-b) piridina como inibidores sem ser da sintase que podem ser induzidos
RU99125040A (ru) Сульфозамещенные фталоцианины как фотосенсибилизаторы для фотодинамической терапии
EA200500903A1 (ru) Силиловые простые эфиры
CY1105981T1 (el) Ενωσεις 5-πυριδυλ-1,3-αζολιου, μεθοδοι παρασκευης αυτων και χρηση αυτων

Legal Events

Date Code Title Description
8364 No opposition during term of opposition